The safety and tolerability study of tiozonid in single dose with it increasing

A study of the safety and tolerability tiozonid manufacturing by JSC «Pharm-Sintez» (Russia) at the single dose with it increasing (25, 200, 400 and 600 mg) in healthy volunteers. In each group, the volunteers were enrolled sequentially, based on the interim evaluation of safety parameters. This stu...

Full description

Bibliographic Details
Main Authors: A. U. Savchenko, G. V. Ramenskaya, M. S. Bourenkov
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-05-01
Series:Качественная клиническая практика
Subjects:
Online Access:https://www.clinvest.ru/jour/article/view/56
_version_ 1797262139924152320
author A. U. Savchenko
G. V. Ramenskaya
M. S. Bourenkov
author_facet A. U. Savchenko
G. V. Ramenskaya
M. S. Bourenkov
author_sort A. U. Savchenko
collection DOAJ
description A study of the safety and tolerability tiozonid manufacturing by JSC «Pharm-Sintez» (Russia) at the single dose with it increasing (25, 200, 400 and 600 mg) in healthy volunteers. In each group, the volunteers were enrolled sequentially, based on the interim evaluation of safety parameters. This study was conducted in compliance with the requirements of legislation and the ethical principles set forth in the Federal Law «On Circulation of Medicines» (number 61-FZ of April 12, 2010), the Declaration of Helsinki of the World Medical Association (1964, with subsequent amendments), GOST R 52379-2005 «Good clinical practice» The study drug tiozonid manufacturing by JSC «Pharm-Sintez» (Russia) has shown a sufficiently high safety and well-tolerated at single oral doses in the range of 25-600 mg.
first_indexed 2024-04-24T23:52:22Z
format Article
id doaj.art-cde59ae9c885437487831b6f11d05cf6
institution Directory Open Access Journal
issn 2588-0519
2618-8473
language Russian
last_indexed 2024-04-24T23:52:22Z
publishDate 2018-05-01
publisher Izdatelstvo OKI
record_format Article
series Качественная клиническая практика
spelling doaj.art-cde59ae9c885437487831b6f11d05cf62024-03-14T18:09:03ZrusIzdatelstvo OKIКачественная клиническая практика2588-05192618-84732018-05-0103434856The safety and tolerability study of tiozonid in single dose with it increasingA. U. Savchenko0G. V. Ramenskaya1M. S. Bourenkov2ФГБУН НЦБМТ ФМБА РоссииФГБОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава РоссииАО «Фарм-Синтез»A study of the safety and tolerability tiozonid manufacturing by JSC «Pharm-Sintez» (Russia) at the single dose with it increasing (25, 200, 400 and 600 mg) in healthy volunteers. In each group, the volunteers were enrolled sequentially, based on the interim evaluation of safety parameters. This study was conducted in compliance with the requirements of legislation and the ethical principles set forth in the Federal Law «On Circulation of Medicines» (number 61-FZ of April 12, 2010), the Declaration of Helsinki of the World Medical Association (1964, with subsequent amendments), GOST R 52379-2005 «Good clinical practice» The study drug tiozonid manufacturing by JSC «Pharm-Sintez» (Russia) has shown a sufficiently high safety and well-tolerated at single oral doses in the range of 25-600 mg.https://www.clinvest.ru/jour/article/view/56безопасность и переносимостьтиозонидздоровые добровольцыsafety and tolerabilitytiozonidhealthy volunteers
spellingShingle A. U. Savchenko
G. V. Ramenskaya
M. S. Bourenkov
The safety and tolerability study of tiozonid in single dose with it increasing
Качественная клиническая практика
безопасность и переносимость
тиозонид
здоровые добровольцы
safety and tolerability
tiozonid
healthy volunteers
title The safety and tolerability study of tiozonid in single dose with it increasing
title_full The safety and tolerability study of tiozonid in single dose with it increasing
title_fullStr The safety and tolerability study of tiozonid in single dose with it increasing
title_full_unstemmed The safety and tolerability study of tiozonid in single dose with it increasing
title_short The safety and tolerability study of tiozonid in single dose with it increasing
title_sort safety and tolerability study of tiozonid in single dose with it increasing
topic безопасность и переносимость
тиозонид
здоровые добровольцы
safety and tolerability
tiozonid
healthy volunteers
url https://www.clinvest.ru/jour/article/view/56
work_keys_str_mv AT ausavchenko thesafetyandtolerabilitystudyoftiozonidinsingledosewithitincreasing
AT gvramenskaya thesafetyandtolerabilitystudyoftiozonidinsingledosewithitincreasing
AT msbourenkov thesafetyandtolerabilitystudyoftiozonidinsingledosewithitincreasing
AT ausavchenko safetyandtolerabilitystudyoftiozonidinsingledosewithitincreasing
AT gvramenskaya safetyandtolerabilitystudyoftiozonidinsingledosewithitincreasing
AT msbourenkov safetyandtolerabilitystudyoftiozonidinsingledosewithitincreasing